4 | 1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acidIBA
03/2024
-
06/2022 |
3 | Trastuzumab (Herceptin)FDA Link
09/2023
-
06/2022 |
2 | human ERBB2 proteinIBA
02/2023
-
06/2022 |
2 | AntigensIBA
10/2021
-
05/2019 |
2 | lutetium Lu 177 dotatateIBA
01/2021
-
09/2020 |
2 | DOTA(0)-Tyr(3)-Thr(8)- 90Y-octreotateIBA
01/2021
-
09/2020 |
2 | Radioisotopes (Radionuclides)IBA
01/2021
-
09/2020 |
2 | Peptide Receptors (Peptide Receptor)IBA
01/2021
-
09/2020 |
1 | PorphyrinsIBA
03/2024 |
1 | duramycinIBA
12/2023 |
1 | Antimicrobial PeptidesIBA
11/2023 |
1 | 1- (1,3- carboxypropyl)- 4,7- carboxymethyl- 1,4,7- triazacyclononaneIBA
11/2023 |
1 | ubiquicidin 31-38IBA
11/2023 |
1 | AcidsIBA
11/2023 |
1 | Chelating AgentsIBA
11/2023 |
1 | IodineIBA
10/2023 |
1 | Rituximab (Mabthera)FDA Link
09/2023 |
1 | Lutetium-177IBA
09/2023 |
1 | Humanized Monoclonal AntibodiesIBA
09/2023 |
1 | Peptides (Polypeptides)IBA
03/2023 |
1 | Bombesin Receptors (Bombesin Receptor)IBA
03/2023 |
1 | Therapeutic UsesIBA
02/2023 |
1 | pertuzumabIBA
06/2022 |
1 | LigandsIBA
06/2022 |
1 | RadiopharmaceuticalsIBA
10/2021 |
1 | Hormones (Hormone)IBA
10/2021 |
1 | gallium 68 PSMA-11IBA
09/2021 |
1 | Hemoglobins (Hemoglobin)IBA
01/2021 |
1 | Somatostatin Receptors (Somatostatin Receptor)IBA
01/2021 |
1 | N,N'- bis(2- hydroxy- 5- (ethylene- beta- carboxy)benzyl)ethylenediamine N,N'-diacetic acidIBA
05/2019 |
1 | Membrane Glycoproteins (Membrane Glycoprotein)IBA
05/2019 |